跳至主要内容
临床试验/ISRCTN89405844
ISRCTN89405844进行中(未招募)Unknown

Exacerbation prevention in COPD - effect of home high-flow therapy versus usual care on hospital readmission or death after an acute chronic obstructive pulmonary disease (COPD) exacerbation: a UK-based multicentre randomised clinical trial

Guy's and St Thomas' NHS Foundation Trust0 个研究点目标入组 502 人开始时间: 2023年5月23日最近更新:

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
502

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Severe exacerbation of COPD*
  • 2. Age 40-80 years
  • 3. Diagnosis of COPD as defined by GOLD criteria
  • 4. Smoking history of >10 pack years
  • 5. Forced expiratory volume in 1 second (FEV1) <80% predicted
  • 6. FEV1/FVC < 0.7**
  • *Severity defined by admission to hospital (acute admissions unit or hospital ward)
  • **post bronchodilator

排除标准

  • 1. Significant obesity (BMI >35kg/m²)
  • 2. Clinically significant obstructive sleep apnoea syndrome requiring PAP therapy (see screening procedures for more detail)
  • 3. Major non-COPD chronic co-morbidity that may significantly contribute to risk of readmission or death within 1 year
  • 4. Home PAP or NIV therapy

研究者

相似试验